Breast Cancer Research and Treatment, 0167-6806

Journal

  1. 2019
  2. Hoveling, L. A., van Maaren, M. C., Hueting, T., Strobbe, L. J. A., Hendriks, M. P., Sonke, G. S., & Siesling, S. (2019). Validation of the online prediction model CancerMath in the Dutch breast cancer population. Breast Cancer Research and Treatment, 178(3), 665-681. https://doi.org/10.1007/s10549-019-05399-2
  3. Heemskerk-Gerritsen, B. A. M., Jager, A., Koppert, L. B., Obdeijn, A. I-M., Collée, M., Meijers-Heijboer, H. E. J., Jenner, D. J., Oldenburg, H. S. A., van Engelen, K., de Vries, J., van Asperen, C. J., Devilee, P., Blok, M. J., Kets, C. M., Ausems, M. G. E. M., Seynaeve, C., Rookus, M. A., & Hooning, M. J. (2019). Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers. Breast Cancer Research and Treatment, 177(3), 723-733. https://doi.org/10.1007/s10549-019-05345-2
  4. Sentinel Node Recurrent Breast Can, Poodt, I. G. M., Schipper, R-J., de Greef, B. T. A., Vugts, G., Maaskant-Braat, A. J. G., Jansen, F. H., Wyndaele, D. N. J., Voogd, A. C., & Nieuwenhuijzen, G. A. P. (2019). Screening for distant metastases in patients with ipsilateral breast tumor recurrence: the impact of different imaging modalities on distant recurrence-free interval. Breast Cancer Research and Treatment, 175(2), 419-428. https://doi.org/10.1007/s10549-019-05205-z
  5. 2018
  6. 2017
  7. Hamdi, Y., Soucy, P., Kuchenbaeker, K. B., Pastinen, T., Droit, A., Lemacon, A., Adlard, J., Aittomaki, K., Andrulis, I. L., Arason, A., Arnold, N., Arun, B. K., Azzollini, J., Bane, A., Barjhoux, L., Barrowdale, D., Benitez, J., Berthet, P., Blok, M. J., ... kConFab Investigators (2017). Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: Identification of a modifier of breast cancer risk at locus 11q22.3. Breast Cancer Research and Treatment, 161(1), 117-134. https://doi.org/10.1007/s10549-016-4018-2
  8. 2016
  9. Lo-Fo-Wong, D. N. N., de Haes, H. C. J. M., Aaronson, N. K., van Abbema, D. L., den Boer, M. D., van Hezewijk, M., Immink, M., Kaptein, A. A., Menke-Pluijmers, M. B. E., Reyners, A. K. L., Russell, N. S., Schriek, M., Sijtsema, S., van Tienhoven, G., & Sprangers, M. A. G. (2016). Predictors of enduring clinical distress in women with breast cancer. Breast Cancer Research and Treatment, 158(3), 563-572. https://doi.org/10.1007/s10549-016-3896-7
  10. 2015
  11. Dekker, T. J. A., ter Borg, S., Hooijer, G. K. J., Meijer, S. L., Wesseling, J., Boers, J. E., Schuuring, E., Bart, J., van Gorp, J., Bult, P., Riemersma, S. A., van Deurzen, C. H. M., Sleddens, H. F. B. M., Mesker, W. E., Kroep, J. R., Smit, V. T. H. B. M., & van de Vijver, M. J. (2015). Erratum to: Quality assessment of estrogen receptor and progesterone receptor testing in breast cancer using a tissue microarray-based approach (vol 152, pg 247, 2015). Breast Cancer Research and Treatment, 152(2), 253. https://doi.org/10.1007/s10549-015-3478-0
  12. Dekker, T. J. A., ter Borg, S., Hooijer, G. K. J., Meijer, S. L., Wesseling, J., Boers, J. E., Schuuring, E., Bart, J., van Gorp, J., Bult, P., Riemersma, S. A., van Deurzen, C. H. M., Sleddens, H. F. B. M., Mesker, W. E., Kroep, J. R., Smit, V. T. H. B. M., & van de Vijver, M. J. (2015). Quality assessment of estrogen receptor and progesterone receptor testing in breast cancer using a tissue microarray-based approach. Breast Cancer Research and Treatment, 152(2), 247-252. https://doi.org/10.1007/s10549-015-3444-x
  13. 2014
  14. Mast, M. E., Vredeveld, E. J., Credoe, H. M., van Egmond, J., Heijenbrok, M. W., Hug, E. B., Kalk, P., van Kempen-Harteveld, L. M. L., Korevaar, E. W., van der Laan, H. P., Langendijk, J. A., Rozema, H. J. E., Petoukhova, A. L., Schippers, J. M., Struikmans, H., & Maduro, J. H. (2014). Whole breast proton irradiation for maximal reduction of heart dose in breast cancer patients. Breast Cancer Research and Treatment, 148(1), 33-39. https://doi.org/10.1007/s10549-014-3149-6
  15. de Glas, N. A., Hamaker, M. E., Kiderlen, M., de Craen, A. J. M., Mooijaart, S. P., van de Velde, C. J. H., van Munster, B. C., Portielje, J. E. A., Liefers, G. J., & Bastiaannet, E. (2014). Choosing relevant endpoints for older breast cancer patients in clinical trials: an overview of all current clinical trials on breast cancer treatment. Breast Cancer Research and Treatment, 146(3), 591-597. https://doi.org/10.1007/s10549-014-3038-z
  16. Siesling, S., Tjan-Heijnen, V. C. G., de Roos, M., Snel, Y., van Dalen, T., Wouters, M. W., Struikmans, H., van der Hoeven, J. J. M., Maduro, J. H., & Visser, O. (2014). Impact of hospital volume on breast cancer outcome: A population-based study in the Netherlands. Breast Cancer Research and Treatment, 147(1), 177-184. https://doi.org/10.1007/s10549-014-3075-7
  17. Milde-Langosch, K., Karn, T., Schmidt, M., Eulenburg, C. Z., Oliveira-Ferrer, L., Wirtz, R. M., Schumacher, U., Witzel, I., Schuetze, D., & Mueller, V. (2014). Prognostic relevance of glycosylation-associated genes in breast cancer. Breast Cancer Research and Treatment, 145(2), 295-305. https://doi.org/10.1007/s10549-014-2949-z
  18. 2013
  19. 2012
  20. ROLL study group, Postma, E. L., Verkooijen, H. M., van Esser, S., Hobbelink, M. G., van der Schelling, G. P., Koelemij, R., Witkamp, A. J., Contant, C., van Diest, P. J., Willems, S. M., Borel Rinkes, I. H. M., van den Bosch, M. A. A. J., Mali, W. P., & van Hillegersberg, R. (2012). Efficacy of 'radioguided occult lesion localisation' (ROLL) versus 'wire-guided localisation' (WGL) in breast conserving surgery for non-palpable breast cancer: a randomised controlled multicentre trial. Breast Cancer Research and Treatment, 136(2), 469-478. https://doi.org/10.1007/s10549-012-2225-z
  21. Keyzer-Dekker, C. M. G., van Esch, L., de Vries, J., Ernst, M., Nieuwenhuijzen, G. A. P., Roukema, J. A., & van der Steeg, A. F. W. (2012). An abnormal screening mammogram causes more anxiety than a palpable lump in benign breast disease. Breast Cancer Research and Treatment, 134(1), 253-258. https://doi.org/10.1007/s10549-012-2025-5
  22. van Nes, J. G. H., Fontein, D. B. Y., Hille, E. T. M., Voskuil, D. W., van Leeuwen, F. E., de Haes, J. C. J. M., Putter, H., Seynaeve, C., Nortier, J. W. R., & van de Velde, C. J. H. (2012). Quality of life in relation to tamoxifen or exemestane treatment in postmenopausal breast cancer patients: a Tamoxifen Exemestane Adjuvant Multinational (TEAM) Trial side study. Breast Cancer Research and Treatment, 134(1), 267-276. https://doi.org/10.1007/s10549-012-2028-2
  23. van Nes, J. G. H., de Kruijf, E. M., Putter, H., Faratian, D., Munro, A., Campbell, F., Smit, V. T. H. B. M., Liefers, G-J., Kuppen, P. J. K., van de Velde, C. J. H., & Bartlett, J. M. S. (2012). Co-expression of SNAIL and TWIST determines prognosis in estrogen receptor-positive early breast cancer patients. Breast Cancer Research and Treatment, 133(1), 49-59. https://doi.org/10.1007/s10549-011-1684-y
  24. 2011
  25. Peixoto, A., Santos, C., Pinheiro, M., Pinto, P., Soares, M. J., Rocha, P., Gusmao, L., Amorim, A., van der Hout, A., Gerdes, A-M., Thomassen, M., Kruse, T. A., Cruger, D., Sunde, L., Bignon, Y-J., Uhrhammer, N., Cornil, L., Rouleau, E., Lidereau, R., ... Teixeira, M. R. (2011). International distribution and age estimation of the Portuguese BRCA2 c.156_157insAlu founder mutation. Breast Cancer Research and Treatment, 127(3), 671-679. https://doi.org/10.1007/s10549-010-1036-3
  26. Campa, D., Claus, R., Dostal, L., Stein, A., Chang-Claude, J., Meidtner, K., Boeing, H., Olsen, A., Tjonneland, A., Overvad, K., Rodriguez, L., Bonet, C., Sanchez, M-J., Amiano, P., Huerta, J. M., Barricarte, A., Khaw, K-T., Wareham, N., Travis, R. C., ... Kaaks, R. (2011). Variation in genes coding for AMP-activated protein kinase (AMPK) and breast cancer risk in the European Prospective Investigation on Cancer (EPIC). Breast Cancer Research and Treatment, 127(3), 761-767. https://doi.org/10.1007/s10549-010-1269-1
  27. Manders, P., Pijpe, A., Hooning, M. J., Kluijt, I., Vasen, H. F. A., Hoogerbrugge, N., van Asperen, C. J., Meijers-Heijboer, H., Ausems, M. G. E. M., van Os, T. A., Gomez-Garcia, E. B., Brohet, R. M., van Leeuwen, F. E., Rookus, M. A., & HEBON (2011). Body weight and risk of breast cancer in BRCA1/2 mutation carriers. Breast Cancer Research and Treatment, 126(1), 193-202. https://doi.org/10.1007/s10549-010-1120-8
  28. Effenberger, K. E., Borgen, E., zu Eulenburg, C., Bartkowiak, K., Grosser, A., Synnestvedt, M., Kaaresen, R., Brandt, B., Nesland, J. M., Pantel, K., & Naume, B. (2011). Detection and clinical relevance of early disseminated breast cancer cells depend on their cytokeratin expression pattern. Breast Cancer Research and Treatment, 125(3), 729-738. https://doi.org/10.1007/s10549-010-0911-2
  29. 2010
  30. Witzel, I., Loibl, S., von Minckwitz, G., Mundhenke, C., Huober, J., Hanusch, C., Henschen, S., Hauschild, M., Lantzsch, T., Tesch, H., Latos, K., Just, M., Hilfrich, J., Barinoff, J., zu Eulenburg, C., Roller, M., Untch, M., & Mueller, V. (2010). Monitoring serum HER2 levels during neoadjuvant trastuzumab treatment within the GeparQuattro trial. Breast Cancer Research and Treatment, 123(2), 437-445. https://doi.org/10.1007/s10549-010-1030-9
  31. Obdeijn, I-M. A., Loo, C. E., Rijnsburger, A. J., Wasser, M. N. J. M., Bergers, E., Kok, T., Klijn, J. G. M., & Boetes, C. (2010). Assessment of false-negative cases of breast MR imaging in women with a familial or genetic predisposition. Breast Cancer Research and Treatment, 119(2), 399-407. https://doi.org/10.1007/s10549-009-0607-7
  32. 2009
  33. 2008
  34. Hoogendoorn, W. E., Hollema, H., van Boven, H. H., Bergman, E., de Leeuw-Mantel, G., Platteel, I., Fles, R., Nederlof, P. M., Mourits, M. J. E., van Leeuwen, F. E., & Comprehensive Canc Ctr TAMARISK Gr (2008). Prognosis of uterine corpus cancer after tamoxifen treatment for breast cancer. Breast Cancer Research and Treatment, 112(1), 99-108. https://doi.org/10.1007/s10549-007-9823-1
  35. van der Groep, P., Bouter, A., Menko, F. H., van der Wall, E., & van Diest, P. J. (2008). High frequency of HIF-1 alpha overexpression in BRCA1 related breast cancer. Breast Cancer Research and Treatment, 111(3), 475-480. https://doi.org/10.1007/s10549-007-9817-z
  36. 2007
  37. Kriege, M., Brekelmans, C. T. M., Peterse, H., Obdeijn, I. M., Boetes, C., Zonderland, H. M., Muller, S. H., Kok, T., Manoliu, R. A., Besnard, A. P. E., Tilanus-Linthorst, M. M. A., Seynaeve, C., Bartels, C. C. M., Meijer, S., Oosterwijk, J. C., Hoogerbrugge, N., Tollenaar, R. A. E. M., de Koning, H. J., Rutgers, E. J. T., & Klijn, J. G. M. (2007). Tumor characteristics and detection method in the MRISC screening program for the early detection of hereditary breast cancer. Breast Cancer Research and Treatment, 102(3), 357-363. https://doi.org/10.1007/s10549-006-9341-6
  38. 2006
  39. Kriege, M., Brekelmans, C. T. M., Obdeijn, I. M., Boetes, C., Zonderland, H. M., Muller, S. H., Kok, T., Manoliu, R. A., Besnard, A. P. E., Tilanus-Linthorst, M. M. A., Seynaeve, C., Bartels, C. C. M., Kaas, R., Meijer, S., Oosterwijk, J. C., Hoogerbrugge, N., Tollenaar, R. A. E. M., Rutgers, E. J. T., de Koning, H. J., & Klijn, J. G. M. (2006). Factors affecting sensitivity and specificity of screening mammography and MRI in women with an inherited risk for breast cancer. Breast Cancer Research and Treatment, 100(1), 109-119. https://doi.org/10.1007/s10549-006-9230-z
  40. 2004
  41. 2002
  42. Hoorntje, LE., Peeters, PHM., Rinkes, IHMB., Verkooijen, HM., Pijnappel, RM., & Mali, WPTM. (2002). Stereotactic large core needle biopsy for all nonpalpable breast lesions ? Breast Cancer Research and Treatment, 73(2), 177-182.
  43. 1996

ID: 1584391